Trump Calls for Lower Drug Prices, Fewer Regulations in Meeting with Pharmaceutical Executives

The Washington Post, January 31, 2017. President Trump met with leaders of some of the world’s biggest pharmaceutical companies Tuesday and emphasized the need to lower “astronomical” drug prices, decrease regulations and bring more drug manufacturing into the United States. “There are many empty positions at the FDA,” said Diana Zuckerman, president of the National Center for Health Research. The recently enacted 21st Century Cures law provided for additional hiring authority. “But with the hiring freeze, will they be able to hire anyone?” she asked.

Read More »

Trump Vows to Ease Rules for Drug Makers, But Again Zeros in on Prices

The New York Times, January 31, 2017. President Trump promised some of the nation’s top drug company executives in a meeting at the White House on Tuesday that he would slash regulations at the Food and Drug Administration and make it easier for them to manufacture products in the United States. “Streamlining drug approvals sounds good, but the agency has already weakened approval standards and patients are paying the price — hugely expensive drugs that don’t even work,” said Diana Zuckerman, president of the National Center for Health Research, a Washington research group that advocates strong safety and efficacy standards. She recently studied expensive new cancer drugs and found that many did not help patients feel better or live longer.

Read More »